Advances in automated docking applied to human immunodeficiency virus type 1 protease.
Miller
M D
MD
Department of Molecular Systems, Merck Research Laboratories, West Point, Pennsylvania 19486.
Sheridan
R P
RP
Kearsley
S K
SK
Underwood
D J
DJ
D003198:Computer Simulation; D016208:Databases, Factual; D015195:Drug Design; D016333:HIV Protease / Q000737:chemistry* / Q000378:metabolism; D017320:HIV Protease Inhibitors / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology; D015497:HIV-1 / Q000201:enzymology*; D008024:Ligands; D008958:Models, Molecular; D015394:Molecular Structure; D010455:Peptides / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology; D011485:Protein Binding; D011487:Protein Conformation; D012984:Software; D013379:Substrate Specificity
D017320:HIV Protease Inhibitors; D008024:Ligands; D010455:Peptides; D016333:HIV Protease